Tranzyme Pharma Appoints Pharmaceutical Industry Veteran John H. Johnson as Chairman of its Board of Directors
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Tranzyme Pharma today announced the appointment of John H. Johnson as Chairman of its Board of Directors. Mr. Johnson currently serves as President, Lilly Oncology and Senior Vice President, Eli Lilly and Company.